... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
oxygen molecular entity >
organooxygen compound >
carbonyl compound >
2-[(3s,6as,8r,10as)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-(phenylmethyl)acetamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
2-[(3s,6as,8r,10as)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-(phenylmethyl)acetamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
2-[(3s,6as,8r,10as)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-(phenylmethyl)acetamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic oxo compound >
carbonyl compound >
2-[(3s,6as,8r,10as)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-(phenylmethyl)acetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic oxo compound >
carbonyl compound >
2-[(3s,6as,8r,10as)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-(phenylmethyl)acetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
heteroatomic molecular entity >
halide >
organohalogen compound >
2-[(3s,6as,8r,10as)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-(phenylmethyl)acetamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
halogen molecular entity >
halide >
organohalogen compound >
2-[(3s,6as,8r,10as)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-(phenylmethyl)acetamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organohalogen compound >
2-[(3s,6as,8r,10as)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-(phenylmethyl)acetamide
Preferred term
2-[(3s,6as,8r,10as)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-n-(phenylmethyl)acetamide
inchi
-
InChI=1S/C25H29FN2O5/c26-21-9-5-4-8-20(21)25(31)28-14-18(29)15-32-16-23-22(28)11-10-19(33-23)12-24(30)27-13-17-6-2-1-3-7-17/h1-9,18-19,22-23,29H,10-16H2,(H,27,30)/t18-,19+,22-,23+/m0/s1
inchikey
-
SAIBSAHLIFBZIR-JFSTXAPLSA-N
smiles
-
C1C[C@H]2[C@@H](COC[C@H](CN2C(=O)C3=CC=CC=C3F)O)O[C@H]1CC(=O)NCC4=CC=CC=C4
-
2 [(3S,6aS,8R,10aS) 1 [(2 fluorophenyl) oxomethyl] 3 hydroxy 3,4,6,6a,8,9,10,10a octahydro 2H pyrano[2,3 c][1,5]oxazocin 8 ylmethyl] N (phenacetayl)
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:129621